Skip to main content

Year: 2024

Winnebago Industries Reports First Quarter Fiscal 2025 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

— Overall Performance Reflects Challenging Outdoor Recreation Market Environment — — Barletta Continues to Expand U.S. Aluminum Pontoon Market Share, Driving Growth of Marine Segment — — Company Repurchases $30 Million of Shares During First Quarter — — Fiscal Year 2025 EPS Guidance Range Narrowed; Midpoint Maintained — EDEN PRAIRIE, Minn., Dec. 20, 2024 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today reported financial results for the Company’s first quarter fiscal 2025. First Quarter Fiscal 2025 Financial SummaryRevenues of $625.6 million Gross profit of $76.8 million, representing 12.3% gross margin Net loss per diluted share of $0.18 Adjusted net loss per diluted share of $0.03(1)CEO Commentary“As expected,...

Continue reading

JPMorgan Asset Management (Canada) Inc. Exchange Traded Funds 2024 Final Annual Reinvested Capital Gain Distributions

Written by Customer Service on . Posted in Dividend Reports And Estimates.

TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) — J. P. Morgan Asset Management (JPMAM)* today announced the final annual reinvested capital gain distributions for the below listed JPMorgan ETFs (the “Funds”) for the 2024 tax year. The distributions are for the annual non-cash capital gains distributions, which are typically reinvested in additional units of the respective funds at the year-end, and do not include ongoing monthly, quarterly, semi-annual, or annual cash distribution amounts. The additional units will be immediately consolidated with the previously outstanding units such that the number of outstanding units following the distribution will equal the number of units outstanding prior to the distribution. The actual taxable amounts of cash distributions for 2024, including the tax characteristics of the distributions, will...

Continue reading

JPMorgan Announces Estimated Cash Distributions for the JPMorgan ETFs

Written by Customer Service on . Posted in Dividend Reports And Estimates.

TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) — J. P. Morgan Asset Management (JPMAM)* today announced the estimated December 2024 cash distributions for the below listed JPMorgan ETFs. The JPMorgan ETFs trade on the Toronto Stock Exchange (TSX). Unitholders of record on December 31, 2024 will receive cash distributions payable on January 9, 2025. JPMAM expects to issue a press release on or about December 30, 2024, which will provide the final amounts for the funds. The Estimated Cash Distribution Per Unit is subject to change. Please note that these are estimated amounts only as of December 15, 2024 and could change if the JPMorgan ETFs experience subscriptions or redemptions prior to the ex-dividend date. Details of the “Per Unit” distributions are as follows:JPMorgan ETF name Ticker symbol Estimated Cash Distribution Per Unit...

Continue reading

Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial

Written by Customer Service on . Posted in Public Companies.

Bagsværd, Denmark, 20 December 2024 – Novo Nordisk today announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE programme. REDEFINE 1 is a 68-week efficacy and safety trial investigating subcutaneous CagriSema (a fixed dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg) compared to the individual components cagrilintide 2.4 mg, semaglutide 2.4 mg and placebo, all administered once-weekly. The trial included 3,417 randomised people with obesity or overweight with one or more comorbidities and a mean baseline body weight of 106.9 kg. The trial achieved its primary endpoint by demonstrating a statistically significant and superior weight loss at week 68 with CagriSema versus placebo. The REDEFINE 1 trial was based on a flexible protocol, allowing patients to modify their dosing throughout the trial....

Continue reading

Correction: Scatec ASA: Mandatory notification of trade by primary insider

Written by Customer Service on . Posted in Public Companies.

Correction: The shares were bought by MMH Nysteen Invest AS, a company controlled by board member Maria Moræus Hanssen and related parties.Oslo, 20 December 2024: MMH Nysteen Invest AS, a company controlled by board member Maria Moræus Hanssen and related parties has on 20 December bought 2,575 shares in Scatec ASA at an average price per share of NOK 77.1. After the transaction MMH Nysteen Invest AS owns 13,615 shares in Scatec ASA.Attached is the notification of the transaction in accordance with the Market Abuse Regulation Article 19. This information is subject to the disclosure requirements pursuant to the Market Abuse Regulation article 19 and section 5-12 of the Norwegian Securities Trading act.Attachment241220 – Notification of trade primary insiders – MMH Nysteen Invest AS

Continue reading

NIP Group Enters the MOBA Game Arena with Re: Aetatis, Accelerating Growth in Digital Entertainment

Written by Customer Service on . Posted in Public Companies.

SHENZHEN, China, Dec. 20, 2024 (GLOBE NEWSWIRE) — NIP Group Inc. (NASDAQ: NIPG) (“NIP Group” or the “Company”), a leading digital entertainment company, is breaking new ground with the introduction of its first MOBA game: Re: Aetatis. This highly anticipated cutting-edge sci-fi MOBA mobile game begins open beta testing on December 24, 2024, inviting players to experience the next evolution in competitive gaming. Re: Aetatis marks NIP Group’s bold entry into the dynamic game publishing market and a major milestone for the Company’s evolution from a top esports organization to a global digital entertainment leader. Following the launch of reservations, Re: Aetatis has garnered significant attention and recognition from players and is poised to become a flagship title in NIP Group’s emerging game portfolio. NIP Group is...

Continue reading

Vaisala Corporation: Managers’ Transactions – Rosenberg, Lotte

Written by Customer Service on . Posted in Public Companies.

Vaisala CorporationManagers’ TransactionsDecember 20, 2024, at 11:30 a.m. (EET) Vaisala Corporation: Managers’ Transactions – Rosenberg, Lotte ____________________________________________ Person subject to the notification requirementName: Rosenberg, LottePosition: Member of the Board/Deputy memberIssuer: Vaisala OyjLEI: 743700RNDD7KU11HW873 Notification type: INITIAL NOTIFICATIONReference number: 88612/6/6____________________________________________ Transaction date: 2024-12-19Venue: TQEAInstrument type: SHAREISIN: FI0009900682Nature of the transaction: DISPOSAL Transaction details(1): Volume: 4 Unit price: 46.65 EUR (2): Volume: 8 Unit price: 46.65 EUR (3): Volume: 23 Unit price: 46.5 EUR (4): Volume: 51 Unit price: 46.65 EUR (5): Volume: 51 Unit price: 46.65 EUR (6): Volume: 49 Unit price: 46.7 EUR (7): Volume: 214 Unit price: 46.65...

Continue reading

Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Written by Customer Service on . Posted in Public Companies.

Tokyo, Japan and Cambridge, UK, 20 December 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – announces that Chris Cargill, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, 15 January 2025 at 3:00 p.m. PST. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at this weblink. Presentation slides will be made available through the investor section of the Company’s website. –END– About Nxera PharmaNxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. In addition to several products being commercialized in Japan,...

Continue reading

EIB submits SEC Form 18-K/A Amendment No.9 – June 2024 EIB Group Risk Management Disclosure Report

Written by Customer Service on . Posted in Public Companies.

For immediate release 20 December 2024 EIB submits SEC Form 18-K/A Amendment No. 9 The European Investment Bank (EIB) has submitted its SEC Form 18-K/A Amendment No. 9. To view the document, please go to: EDGAR Filing Documents for 0000950157-24-001686 The 18-K/A has also been posted on the EIB website: Amendment to the Annual Report 2023 (Form 18-K/A Amendment No 9) ENDS

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.